Antihistamines
Stored pharmaceutical residues, not the drug's active role, are the concern here. When antihistamine deposits begin clearing from fatty and nerve tissue, the release produces acute nausea and vomiting unless a cheese protocol is in place to intercept them.
Antihistamines appear in Aajonus's framework primarily as a category of stored pharmaceutical toxin, something that accumulates in body tissues and must eventually be expelled through detoxification. He did not discuss antihistamines in depth as a standalone subject, but he addressed them specifically in the context of what a practitioner needs to know before guiding someone through a dietary transition, because the manner in which antihistamine residues exit the body produces symptoms that can become severe if not managed.
His concern was not with the biochemical mechanism of the drug in its original pharmaceutical role but with what happens after the drug is deposited in tissue and the body later attempts to clear it. Like other pharmaceutical and recreational substances he grouped together under the heading of stored chemical toxins, antihistamines represented a category of industrial poison that the body could not safely metabolize at the time of ingestion and therefore sequestered in fatty tissues, nerve tissue, or organ walls, where it would remain until conditions allowed for elimination.
Antihistamines In The Framework
Aajonus grouped antihistamines with substances like speed and other pharmaceutical drugs as chemicals that deposit in the body and later dump their toxic load into the digestive system and bloodstream during cleansing cycles. He did not distinguish between different classes of antihistamines in the available source material. The relevant characteristic, from his perspective, was that they were stored toxins that would eventually re-enter circulation when the body began a detoxification process, and that their release could produce intense nausea, vomiting, and general systemic distress if nothing was in place to intercept and bind the chemicals as they moved through the digestive tract.
The Cheese Detoxification Protocol
The most specific guidance Aajonus gave regarding antihistamines was a cheese protocol intended to manage the symptoms that arise when antihistamine residues begin to dump from tissues. He described this in the context of a practitioner taking a client history and said the relevant question to ask was whether the person had taken a lot of aspirin, antihistamines, speed, or similar substances, so that the practitioner would know what might be stored in a given area of the body and what kind of detoxification reaction to anticipate.
His recommendation for antihistamines and speed was the same: have the person eat a thin slice of cheese approximately one eighth of an inch thick by three inches long by two and a half inches wide, or whatever the brick dimension of the available cheese was, roughly five to six times per day. This slice was to be eaten with anything else the person was consuming, not necessarily as a separate meal or at any particular interval, just present alongside whatever they were eating at the time. The instruction was that they simply needed that thin slice to be present in the stomach and intestines at frequent intervals throughout the day.
The purpose of this protocol was to use the cheese as a toxin absorber. Aajonus described cheese as a substance that draws toxins into itself, functioning like a sponge that intercepts chemicals being released from tissues before those chemicals can irritate the stomach lining or enter the bloodstream in concentrations high enough to cause acute symptoms. Without this buffer in place, he stated, the person was going to start vomiting and being nauseous and would not be in a pleasant state generally.
The frequency of five to six thin slices per day was specific to the volume of toxic release anticipated from a history of antihistamine or stimulant use. The slices were thin, not large portions, because the goal was absorption throughout the day rather than a single large intake. The protocol was designed to keep a constant absorptive medium present in the gastrointestinal tract during the entire period when the dumping was occurring.
Distinction from the Aspirin Protocol
Aajonus explicitly noted that the cheese protocol for antihistamines and speed was not the same protocol he used for aspirin. He began to describe a different approach for aspirin detoxification but the source material does not contain the complete answer for that category. The distinction matters because it indicates that he differentiated between classes of pharmaceutical toxins in terms of how they exit the body and what was needed to manage the process, even if the cheese protocol was applicable across antihistamines and stimulants as a group.